Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-280106
Filing Date
2010-12-14
Accepted
2010-12-14 15:02:05
Documents
17
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1641243
2 ACCENTIA'S 2010 EQUITY INCENTIVE PLAN dex10182.htm EX-10.182 68173
3 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 10093
4 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 9943
5 SECTION 906 CERTIFICATION OF CEO dex321.htm EX-32.1 3067
6 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 2923
7 GRAPHIC g123475tx_pg013.jpg GRAPHIC 64288
8 GRAPHIC g123475tx_pg016.jpg GRAPHIC 103644
9 GRAPHIC g123475tx_pg018.jpg GRAPHIC 53185
10 GRAPHIC g123475tx_pg019.jpg GRAPHIC 45678
11 GRAPHIC g123475tx_pg020.jpg GRAPHIC 53741
12 GRAPHIC g123475tx_pg021.jpg GRAPHIC 81497
13 GRAPHIC g123475tx_pg022.jpg GRAPHIC 47605
14 GRAPHIC g123475tx_pg023.jpg GRAPHIC 53416
15 GRAPHIC g123475tx_pg024.jpg GRAPHIC 61573
16 GRAPHIC g123475tx_pg026a.jpg GRAPHIC 70783
17 GRAPHIC g123475tx_pg026b.jpg GRAPHIC 64302
  Complete submission text file 0001193125-10-280106.txt   2702604
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-51383 | Film No.: 101250417
SIC: 2834 Pharmaceutical Preparations